Restore CLINICAL TRIAL
Prospective, Non-Randomized, Concurrently Controlled, Multi-Center Study to Evaluate the Safety and Effectiveness of the Spinal Kinetics™ M6-C Artificial Cervical Disc Compared to Anterior Cervical Discectomy and Fusion (ACDF) for the Treatment of Symptomatic Cervical Radiculopathy
1 other identifier
interventional
258
0 countries
N/A
Brief Summary
This is a prospective, concurrently controlled, multi-center study to evaluate the safety and effectiveness of the Spinal Kinetics M6-C artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF) for the treatment of symptomatic cervical radiculopathy with or without cord compression. Some participating sites will enroll just M6-C patients, while others will enroll just ACDF patients. Patients eligible for study enrollment will present with degenerative cervical radiculopathy requiring surgical intervention, confirmed clinically and radiographically, at one vertebral level from C3 to C7. A total of 243 subjects will be included at up to 20 sites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2014
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2012
CompletedFirst Posted
Study publicly available on registry
June 1, 2012
CompletedStudy Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedSeptember 18, 2019
March 1, 2019
5.7 years
May 24, 2012
September 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Safety Evaluation through 24 months
Evaluate the safety by assessing adverse events and neurological function following implantation with the Spinal Kinetics M6-C artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF)
24 months
Effectiveness Evaluation through 24 months
Evaluate the effectiveness using Neck Disability Index (NDI)
24 months
Secondary Outcomes (1)
Effectiveness of the Spinal Kinetics M6-C artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF)
6 weeks, 3 months, 6 months, 12 months, 24 months
Study Arms (2)
M6-C Artificial Cervical Disc
EXPERIMENTALAnterior Cervical Discectomy and Fusion
ACTIVE COMPARATORInterventions
Cervical fusion
Eligibility Criteria
You may qualify if:
- Diagnosis of degenerative cervical radiculopathy with or without spinal cord compression requiring surgical treatment at one level from C3 to C7 demonstrated by signs and/or symptoms of disc herniation and/or osteophyte formation (e.g. neck and/or arm pain, radiculopathy, etc.) and is confirmed by patient history and radiographic studies (e.g. MRI, CT, x-rays, etc.)
- Inadequate response to conservative medical care over a period of at least 6 weeks
- Neck Disability Index score of ≥ 30% (raw score of ≥ 15/50)
- Neck or arm pain VAS ≥ 4 on a scale of 0 to 10
- Willing and able to comply with the requirements of the protocol including follow-up requirements
- Willing and able to sign a study specific informed consent
- Skeletally mature and ≥ 18 years old and ≤ 75 years old
You may not qualify if:
- More than one cervical level requiring surgery
- Previous anterior cervical spine surgery
- Axial neck pain as the solitary symptom
- Previous posterior cervical spine surgery (e.g., posterior element decompression) that destabilizes the cervical spine
- Advanced cervical anatomical deformity (e.g., ankylosing spondylitis, scoliosis) at the operative or adjacent levels
- Symptomatic facet arthrosis
- Less than 4º of motion in flexion/extension at the index level
- Instability as evidenced by subluxation \> 3 mm at the index or adjacent levels as indicated on flexion/extension x-rays
- Advanced degenerative changes (e.g., spondylosis) at the index vertebral level as evidenced by bridging osteophytes, central disc height \< 4mm and/or \< 50% of the adjacent normal intervertebral disc, or kyphotic deformity \> 11º on neutral x-rays
- Severe cervical myelopathy (i.e., Nurick's Classification \> 2)
- Active systemic infection or infection at the operative site
- Co-morbid medical conditions of the spine or upper extremities that may affect the cervical spine neurological and/or pain assessment
- Metabolic bone disease such as osteoporosis that contradicts spinal surgery (for females over 50 and males over 55 years old, or if the score on the Osteoporosis Self-Assessment Test is \< 2, a dual energy x-ray absorptiometry \[DEXA scan\] of the spine is required; if the bone mineral density T-score in the spine is ≤ -2.5 the patient must be excluded)
- History of an osteoporotic fracture of the spine, hip or wrist
- History of an endocrine or metabolic disorder (e.g., Paget's disease) known to affect bone and mineral metabolism
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Spinal Kineticslead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- since the study is concurrently controlled, masking is not possible
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2012
First Posted
June 1, 2012
Study Start
May 1, 2014
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
September 18, 2019
Record last verified: 2019-03